Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06191796 |
Title | Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Exelixis |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Exelixis Site #8 | Los Angeles | California | 90033 | United States | Details | |
Exelixis Site #9 | Miami | Florida | 33176 | United States | Details | |
Exelixis Clinical Site #1 | Orlando | Florida | 32804 | United States | Details | |
Exelixis Site #11 | Tampa | Florida | 33612 | United States | Details | |
Exelixis Site #6 | Scarborough | Maine | 04074 | United States | Details | |
Exelixis Site #5 | Saint Louis | Missouri | 63110 | United States | Details | |
Exelixis Site #15 | Bronx | New York | 10469 | United States | Details | |
Exelixis Clinical Site #3 | New Hyde Park | New York | 11776 | United States | Details | |
Exelixis Site #14 | New York | New York | 10028 | United States | Details | |
Exelixis Site #13 | Shirley | New York | 11987 | United States | Details | |
Exelixis Clinical Site #2 | Nashville | Tennessee | 37203 | United States | Details | |
Exelixis Clinical Site #16 | Salt Lake City | Utah | 84112 | United States | Details | |
Exelixis Site #4 | Spokane | Washington | 99208 | United States | Details | |
Exelixis Site #12 | Madison | Wisconsin | 53792 | United States | Details |